A detailed history of Confluence Wealth Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Confluence Wealth Services, Inc. holds 14,985 shares of ABBV stock, worth $3.05 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
14,985
Previous 19,653 23.75%
Holding current value
$3.05 Million
Previous $3.37 Million 12.2%
% of portfolio
0.23%
Previous 0.28%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$163.84 - $199.33 $764,805 - $930,472
-4,668 Reduced 23.75%
14,985 $2.96 Million
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $184,509 - $215,465
1,192 Added 6.46%
19,653 $3.37 Million
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $311,649 - $355,095
1,950 Added 11.81%
18,461 $3.36 Million
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $18,569 - $21,496
139 Added 0.85%
16,511 $2.46 Million
Q2 2023

Aug 01, 2023

BUY
$132.51 - $164.9 $3,312 - $4,122
25 Added 0.15%
16,372 $2.21 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $54,517 - $62,785
377 Added 2.36%
16,347 $2.61 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $3,734 - $4,478
-27 Reduced 0.17%
15,970 $2.58 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $1.37 Million - $1.57 Million
-10,219 Reduced 38.98%
15,997 $2.15 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $372,262 - $473,266
2,705 Added 11.51%
26,216 $3.72 Million
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $401,483 - $498,127
3,042 Added 14.86%
23,511 $3.81 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $2.2 Million - $2.78 Million
20,469 New
20,469 $2.77 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Confluence Wealth Services, Inc. Portfolio

Follow Confluence Wealth Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Confluence Wealth Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Confluence Wealth Services, Inc. with notifications on news.